Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial
- 31 May 2005
- journal article
- clinical trial
- Published by Elsevier BV in Lung Cancer
- Vol. 48 (2), 241-246
- https://doi.org/10.1016/j.lungcan.2004.11.006
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Tumor Size Predicts Survival Within Stage IA Non-Small Cell Lung Cancer *Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2003
- Preoperative Evaluation of Patients Undergoing Lung Resection SurgerySocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2003
- Combined modality therapy of early stage nonsmall cell lung cancerRespiratory Care Clinics of North America, 2003
- Molecular staging of lung cancer: Real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer—preliminary results of cancer and leukemia group B trial 9761The Journal of Thoracic and Cardiovascular Surgery, 2002
- Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non-Small-Cell Lung CancerJournal of Clinical Oncology, 2002
- Induction chemotherapy before surgery for early-stage lung cancer: A novel approachThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Revisions in the International System for Staging Lung CancerSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1997
- Regional Lymph Node Classification for Lung Cancer StagingSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1997
- The accuracy of clinical evaluative intrathoracic staging in lung cancer as assessed by postsurgical pathologic stagingCancer, 1990